CT
TEVA icon

Colonial Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Colonial Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-666
Closed -$10.8K – 1140
2024
Q2 		$10.8K Hold
666
– – ﹤0.01% 765
2024
Q1 		$9.4K Hold
666
– – ﹤0.01% 769
2023
Q4 		$6.95K Hold
666
– – ﹤0.01% 762
2023
Q3 		$6.79K Hold
666
– – ﹤0.01% 748
2023
Q2 		$5.01K Hold
666
– – ﹤0.01% 783
2023
Q1 		$5.89K Hold
666
– – ﹤0.01% 730
2022
Q4 		$6.07K Buy
+666
New +$5.81K ﹤0.01% 729

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Colonial Trust's TEVA Position: Q3 2024 in Review

Colonial Trust sold out of Teva Pharmaceuticals (TEVA) in Q3 2024, closing a stake of 666 shares — an estimated $10.8K sold.

Colonial Trust first reported a position in TEVA in Q4 2022 and held it in 7 quarters. The position peaked at $10.8K in Q2 2024. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • Colonial Trust reported no remaining Teva Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Colonial Trust sold 666 Teva Pharmaceuticals shares in Q3 2024, an estimated $10.8K.
  • Colonial Trust first reported a position in Teva Pharmaceuticals in Q4 2022 and held it in 7 quarters.
  • Colonial Trust's Teva Pharmaceuticals position peaked at $10.8K in Q2 2024.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on Colonial Trust's 13F filing for Q3 2024, filed 12 Nov 2024.